Pharvaris (PHVS) Change in Taxes (2021 - 2026)
Pharvaris (PHVS) reported Change in Taxes of -$319738.8 for Q1 2026, little changed on a YoY basis from -$321118.8 in Q1 2025, and up 86.85% quarter-over-quarter from -$2.4 million in Q4 2025.
Pharvaris (PHVS) Change in Taxes (2021 - 2026) Analysis & Trends
Pharvaris has reported Change in Taxes for 6 years, with the latest figure at -$319738.8 in Q1 2026.
- For the quarter ending Q1 2026, Change in Taxes changed 0.43% year-over-year to -$319738.8; the trailing twelve-month figure through Mar 2026 stood at -$2.8 million (down 153.38% YoY), and the FY2025 full-year result was -$2.5 million, up 18.19% from the prior year.
- Change in Taxes for Q1 2026 stood at -$319738.8, up from -$2.4 million in the prior quarter.
- The five-year high for Change in Taxes was $2.4 million in Q3 2022, with the low at -$2.9 million in Q2 2022.
- Historically, Change in Taxes has averaged -$309423.1 across 5 years, with a median of -$229541.0 in 2025.
- The largest YoY upside for Change in Taxes was 3114.12% in 2022 against a maximum downside of 81815.03% in 2022.
- Pharvaris' Change in Taxes stood at $17565.6 in 2022, then tumbled by 1801.86% to -$298941.3 in 2023, then slumped by 48.96% to -$445296.5 in 2024, then tumbled by 445.88% to -$2.4 million in 2025, then jumped by 86.85% to -$319738.8 in 2026.
- The last three Change in Taxes figures came in at -$319738.8 (Q1 2026), -$2.4 million (Q4 2025), and $212147.3 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Pharvaris | 28.66 Bn | 28.37 Bn | - | -319,738.83 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -319,738.83 |
| Mar 31, 2026 | -319,738.83 |
| Dec 31, 2025 | -2.43 Mn |
| Dec 31, 2025 | -2.43 Mn |
| Sep 30, 2025 | 212,147.26 |
| Sep 30, 2025 | 212,147.26 |
| Jun 30, 2025 | -229,541.05 |
| Jun 30, 2025 | -229,541.05 |
| Mar 31, 2025 | -318,370.71 |
| Mar 31, 2025 | -318,370.71 |
| Dec 31, 2024 | -445,296.53 |
| Dec 31, 2024 | -445,296.53 |
| Sep 30, 2024 | -252,690.42 |
| Sep 30, 2024 | -252,690.42 |
| Jun 30, 2024 | -76,053.03 |
| Jun 30, 2024 | -76,053.03 |
| Mar 31, 2024 | -309,740.21 |
| Mar 31, 2024 | -309,740.21 |
| Dec 31, 2023 | -298,941.30 |
| Dec 31, 2023 | -298,941.30 |